Cargando…
Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis
INTRODUCTION: Breast cancer (BC) is the most widely studied disease due to its higher prevalence, heterogeneity and mortality. OBJECTIVES: This study aimed to compare female BC trends among 21 world regions and globally over 28 year of data and to assess the association between sociodemographic tran...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039678/ https://www.ncbi.nlm.nih.gov/pubmed/35499053 http://dx.doi.org/10.1016/j.jare.2021.07.012 |
_version_ | 1784694180882153472 |
---|---|
author | Mubarik, Sumaira Yu, Yong Wang, Fang Malik, Saima Shakil Liu, Xiaoxue Fawad, Muhammad Shi, Fang Yu, Chuanhua |
author_facet | Mubarik, Sumaira Yu, Yong Wang, Fang Malik, Saima Shakil Liu, Xiaoxue Fawad, Muhammad Shi, Fang Yu, Chuanhua |
author_sort | Mubarik, Sumaira |
collection | PubMed |
description | INTRODUCTION: Breast cancer (BC) is the most widely studied disease due to its higher prevalence, heterogeneity and mortality. OBJECTIVES: This study aimed to compare female BC trends among 21 world regions and globally over 28 year of data and to assess the association between sociodemographic transitions and female BC risks. METHODS: We used Global burden of disease study data and measure the female BC burden according to 21 world regions and sociodemographic indices (SDI). Age-period-cohort (APC) analysis was used to estimate time and cohort trend of BC in different SDI regions. RESULTS: By world regions, age-standardised rate of female BC incidence were high in high-income-North America (ASR, 92.9; (95 %UI, 89.2, 96.6)), Western Europe (84.7; (73.4, 97.2)) and Australia (86; (81.7, 90.2)) in 2017. Whereas this rate was significantly increased by 89.5% between 1990 and 2017 in East Asia. We observed negative association between SDI and death, and DALYs in 25th and below percentiles of death and DALYs for the worldwide regions. Further, there was observed a strong negative correlation between SDI and case fatality percent (r(2017) = −0.93; r(1990) = −0.92) in both 2017 and 1990 worldwide and highest case fatality percentage was observed in Central Sub-Saharan Africa. Overall, the risk of case-fatality rate tends to decrease most noticeably in high middle SDI countries, and the reduction of the risk of case-fatality rate in the recent cohort was the lowest in the low SDI countries. CONCLUSIONS: Remarkable variations exist among various regions in BC burden. There is a need to reduce the health burden from BC in less developed and under developing countries, because under-developed countries are facing higher degree of health-related burden. Public health managers should execute more classified and cost-effective screening and treatment interferences to lessen the deaths caused by BC, predominantly among middle and low SDI countries having inadequate healthcare supplies. |
format | Online Article Text |
id | pubmed-9039678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90396782022-04-27 Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis Mubarik, Sumaira Yu, Yong Wang, Fang Malik, Saima Shakil Liu, Xiaoxue Fawad, Muhammad Shi, Fang Yu, Chuanhua J Adv Res Medicine INTRODUCTION: Breast cancer (BC) is the most widely studied disease due to its higher prevalence, heterogeneity and mortality. OBJECTIVES: This study aimed to compare female BC trends among 21 world regions and globally over 28 year of data and to assess the association between sociodemographic transitions and female BC risks. METHODS: We used Global burden of disease study data and measure the female BC burden according to 21 world regions and sociodemographic indices (SDI). Age-period-cohort (APC) analysis was used to estimate time and cohort trend of BC in different SDI regions. RESULTS: By world regions, age-standardised rate of female BC incidence were high in high-income-North America (ASR, 92.9; (95 %UI, 89.2, 96.6)), Western Europe (84.7; (73.4, 97.2)) and Australia (86; (81.7, 90.2)) in 2017. Whereas this rate was significantly increased by 89.5% between 1990 and 2017 in East Asia. We observed negative association between SDI and death, and DALYs in 25th and below percentiles of death and DALYs for the worldwide regions. Further, there was observed a strong negative correlation between SDI and case fatality percent (r(2017) = −0.93; r(1990) = −0.92) in both 2017 and 1990 worldwide and highest case fatality percentage was observed in Central Sub-Saharan Africa. Overall, the risk of case-fatality rate tends to decrease most noticeably in high middle SDI countries, and the reduction of the risk of case-fatality rate in the recent cohort was the lowest in the low SDI countries. CONCLUSIONS: Remarkable variations exist among various regions in BC burden. There is a need to reduce the health burden from BC in less developed and under developing countries, because under-developed countries are facing higher degree of health-related burden. Public health managers should execute more classified and cost-effective screening and treatment interferences to lessen the deaths caused by BC, predominantly among middle and low SDI countries having inadequate healthcare supplies. Elsevier 2021-08-02 /pmc/articles/PMC9039678/ /pubmed/35499053 http://dx.doi.org/10.1016/j.jare.2021.07.012 Text en © 2022 The Authors. Published by Elsevier B.V. on behalf of Cairo University. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Medicine Mubarik, Sumaira Yu, Yong Wang, Fang Malik, Saima Shakil Liu, Xiaoxue Fawad, Muhammad Shi, Fang Yu, Chuanhua Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis |
title | Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis |
title_full | Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis |
title_fullStr | Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis |
title_full_unstemmed | Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis |
title_short | Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis |
title_sort | epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and dalys in 21 world regions and globally, from 1990 to 2017: an age-period-cohort analysis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039678/ https://www.ncbi.nlm.nih.gov/pubmed/35499053 http://dx.doi.org/10.1016/j.jare.2021.07.012 |
work_keys_str_mv | AT mubariksumaira epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT yuyong epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT wangfang epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT maliksaimashakil epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT liuxiaoxue epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT fawadmuhammad epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT shifang epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis AT yuchuanhua epidemiologicalandsociodemographictransitionsoffemalebreastcancerincidencedeathcasefatalityanddalysin21worldregionsandgloballyfrom1990to2017anageperiodcohortanalysis |